glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Dipeptidyl peptidase-4 (DPP-4) inhibitors: dosing, dose adjustment Practice Nursing - GLP-1 receptor
Description
doi: 10.2337/db08-0958 131 NauckMAHeimesaatMMBehleKHolstJJNauckMSRitzelRet al
Meanwhile, multiple variants have also entered the market, including semaglutide injection, semaglutide tablets, liraglutide, tirzepatide, dulaglutide, exenatide, and exenatide extended release
GLP-1R agonists have been extensively used in animal models of skeletal fragility
Diabetes Obes Metab 23(9):21162124
C.KellyJ
Artunc-Ulkumen B, Pala HG, Pala EE, Yavasoglu A, Yigitturk G, Erbas O (2015) Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats
